C12N 2500/98
Xeno-free medium and culture conditions
C12N2500/98 (Xeno-free medium and culture conditions) appears on 126 US grants and 233 published applications in this corpus.
Search patents in C12N- Granted patents
- 126
- Published applications
- 233
- Assignees
- 129
- Inventors
- 407
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 4 |
| 2006 | 1 | 3 |
| 2007 | 1 | 3 |
| 2008 | 3 | 4 |
| 2009 | 1 | 7 |
| 2010 | 1 | 10 |
| 2011 | 3 | 9 |
| 2012 | 5 | 11 |
| 2013 | 3 | 12 |
| 2014 | 6 | 12 |
| 2015 | 8 | 10 |
| 2016 | 6 | 7 |
| 2017 | 5 | 8 |
| 2018 | 6 | 13 |
| 2019 | 11 | 9 |
| 2020 | 11 | 17 |
| 2021 | 9 | 15 |
| 2022 | 4 | 16 |
| 2023 | 5 | 17 |
| 2024 | 8 | 17 |
| 2025 | 16 | 10 |
| 2026 | 8 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells28 Jul 2026US 12,692,479 B2Arizona Board of Regents on behalf of Arizona State University
- Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-22114 Jul 2026US 12,680,078 B2Biolamina AB
- Methods and materials for culturing, proliferating, and differentiating stem cells26 May 2026US 12,637,657 B2Mayo Foundation for Medical Education and Research
- Extracellular vesicles (EVs) derived from mesenchymal stromal cells and method for obtaining said EVs12 May 2026US 12,624,343 B2Exo Biologics SA
- Method for preparing cultures of lactic acid bacteria24 Mar 2026US 12,584,099 B2Chr. Hansen A/S
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells1 Oct 2026US 2026/0297528 A1Arizona Board of Regents on behalf of Arizona State University
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Composition containing extracellular matrix and matrix-bound vesicles for producing extracellular matrix and preparation method therefor24 Sep 2026US 2026/0286308 A1Hlb Cell Co., Ltd
- Generation of induced neutrophils with increased activation and transmigration capabilities10 Sep 2026US 2026/0265695 A1
- Method for producing primed pluripotent stem cells27 Aug 2026US 2026/0250631 A1Kyoto University
Most cited
By later US patents
- Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair304US 6,429,013 B1Artecel Science, Inc. · 2002
- Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid139US 7,442,548 B2Wisconsin Alumni Research Foundation · 2008
- Medium containing pipecholic acid and gamma amino butyric acid and culture of embryonic stem cells138US 7,449,334 B2Wisconsin Alumni Research Foundation · 2008
- Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair129US 6,841,150 B2Artecal, Sciences, Inc. · 2005
- Medium for growing human embryonic stem cells127US 7,297,539 B2Geron Corporation · 2007